MobiHealthNews

Enable Injections brings in $50M for wearable subcutaneous therapeutic delivery devices

Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI ...
MarketWatch

Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) in Sobi Territories

The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...
FierceBiotech

Enable Injections, Incyte ink drug delivery collab focused on chronic blood, bone marrow conditions

Enable Injections, maker of the enFuse wearable drug delivery system, inked a partnership deal to develop and take to market certain assets of the biopharma Incyte. (iStock / Getty Images Plus) Enable ...
Fox 5 San Diego

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories

CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, and ...